62554-90-9

Usage

Uses

Used in Pharmaceutical Industry:
4-Bromo-2,6-dinitroaniline is used as a reactant for the preparation of quinazolinone derivatives, which are known for their antiviral properties. These derivatives are valuable in the development of new antiviral agents to combat viral infections, making 4-Bromo-2,6-dinitroaniline an important compound in the pharmaceutical sector.

Upstream product

• 103-88-8 4-bromoacetanilide 
• 6310-99-2 2,5-dibromo-1,3-dinitro-benzene 
• 51796-82-8 5-bromo-2-chloro-1,3-dinitro-benzene 
• 89365-43-5 4-Brom-2,6-dinitro-phenylazid 
• 106-37-6 1.4-dibromobenzene 
• 106-40-1 4-bromo-aniline 
• 82745-18-4 1-(4-bromophenyl)-3-ethylurea 
• 59280-03-4 N-(4'-bromophenyl)-4-nitrobenzamide 
• 99514-88-2 N-(4'-bromophenyl)-3-nitrobenzamide 
• 7702-38-7 N-(4-bromophenyl)benzamide 
• 861557-71-3 N-ethyl-N'-(4-bromo-2,6-dinitro-phenyl)-N-nitro-urea 
• 7732-18-5 water 
• 195045-44-4 (4-amino-3,5-dinitro-phenyl)-arsonic acid 
• 7726-95-6 bromine 

Downstream Products

• 6310-99-2 2,5-dibromo-1,3-dinitro-benzene 
• 15001-00-0 5-bromo-1,2,3-trinitro-benzene 
• 40466-95-3 4-bromo-2,6-dinitrophenol 
• 15286-74-5 2-[N'-(4-bromo-2,6-dinitro-phenyl)-N-phenyl-hydrazino]-4,5-diphenyl-thiazole 
• 14673-40-6 2-[N'-(4-bromo-2,6-dinitro-phenyl)-N-phenyl-hydrazino]-4-phenyl-thiazole 
• 15001-01-1 2-[N'-(4-bromo-2,6-dinitro-phenyl)-N-phenyl-hydrazino]-thiazole 
• 84752-20-5 4-bromo-6-nitro-1,2-phenylenediamine 
• 100191-18-2 4-bromo-2,6-dinitroiodobenzene 
• 1613696-80-2 1-benzyl-6-bromo-4-nitrobenzimidazole 

Relevant academic research and scientific papers

Synthesis and characterization of heterocyclic conjugated polymers containing planar benzo[c]cinnoline and tetraazapyrene structures for organic field-effect transistor application

Heterocyclic conjugated polymers BZCTVT and TAPTVT containing benzo[c]cinnoline (BZC) and tetraazapyrene (TAP), respectively, were prepared by using Stille coupling polymerization in microwave reactor. BZC and TAP act as acceptors and thiophene-vinylene-t

ORGANIC COMPOUND, CRYSTAL DIELECTRIC LAYER AND CAPACITOR BACKGROUND

The present disclosure provides an organic compound characterized by electronic polarizability and having a following general structural formula: where Core is an aromatic polycyclic conjugated molecule, R1 is group providing solubility of the

BENZIMIDAZOLE DERIVATIVES AS PI3 KINASE INHIBITORS

This invention relates to the use of benzimidazole derivatives for the modulation, notably the inhibition of the activity or function of the phosphoinositide 3′ OH kinase family (hereinafter PI3 kinases), suitably, PI3Kα, PI3Kβ, PI3Kβ, and/or PI3Kγ. Suitably, the present invention relates to the use of benzimidazoles in the treatment of one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries. More suitably, the present invention relates to PI3Kβ selective benzimidazoles compounds for treating cancer.

SUBSTITUTED BENZIMIDAZOLES

The present invention relates to substituted benzimidazole compounds of general formula (I) in which R3, R5 and A are as defined in the claims, to methods of preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyper-proliferative and/or angiogenesis disorder, as a sole agent or in combination with other active ingredients.

ANTIBACTERIAL COMPOSITIONS

Compounds of formula (I) have antibacterial activity: wherein: m is 0 or 1 ; Q is hydrogen or cyclopropyl; AIk is an optionally substituted, divalent C1-C6 alkylene, alkenylene or alkynylene radical which may contain an ether (-O-), thioether (-S-) or amino (-NR)- link, wherein R is hydrogen, -CN or C1-C3 alkyl; X is -C(=O)NR6-, -S(O)NR6-, -C(=O)O- or -S(=O)O- wherein R6 is hydrogen, optionally substituted C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, -Cyc, or -( C1-C3 alkyl)-Cyc wherein Cyc is optionally substituted monocyclic carbocyclic or heterocyclic having 3-7 ring atoms; Z is N or CH, or CF; R2 and R3 are as defined in the description.